Biotech SF
San Francisco Bay Area biotech stories.
Thursday, February 9, 2012
Glaucoma drug developer Altheos adds $12.5M to Series A round
Altheos Inc. raised an additional $12.5 million — pushing its Series A round to a total of $32.5 million — as the South San Francisco company enters a mid-stage study of a glaucoma drug.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment